Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
As of 2026, injectable GHK-Cu is classified as Category 2 by the FDA, restricting it from 503A compounding pharmacies
Manufactured in a GMP-verified facility in Korea
PubMed Central , doi:10.7150/ijms.26340
As of early 2025, the agency had received: 455+ adverse event reports linked to compounded semaglutide 320+ adverse event reports linked to compounded tirzepatide Many of these reports involved dosing errors from patients self-administering incorrect doses from multi-dose vials a format common in compounding but not used by brand-name products (which use pre-filled, single-dose pens with built-in dose controls)
Contact [email protected] for the latest certificate of analysis for this product
Explore CoolSculpting for targeted fat reduction after reaching your weight loss milestones
US$ 24.59
US$ 21.97
US$ 20.99
US$ 22.83
US$ 28.07
US$ 29.18
US$ 21.29
